Aquestive Therapeutics Inc

NASDAQ:AQST   3:59:54 PM EDT
3.68
+0.43 (+13.23%)
Products

Aquestive Announces FDA Acceptance Of NDA Resubmission For Libervant Buccal Film

Published: 07/19/2021 13:44 GMT
Aquestive Therapeutics Inc (AQST) - Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (nda) Resubmission for Libervant™ (diazepam) Buccal Film.
Aquestive Therapeutics Inc - Prescription Drug User Fee Act (pdufa) Target Goal Date Set for December 23, 2021.